LivaNova Plc (LIVN) - Product Pipeline Analysis, 2022 Update

Summary

LivaNova PLC (LivaNova) is a medical technology company that offers medical devices for cardiac surgery and neuromodulation. The company’s neuromodulation products provide vagus nerve stimulation therapy system, an implantable device for the people affected by treatment-resistant epilepsy, depression, heart failure and other chronic disorders. Its cardiovascular surgery products include oxygenators, heart-lung machines, perfusion tubing systems, cannulae and accessories; systems for autotransfusion and autologous blood washing, perfusion charting system, among others. The company offers its solutions to patients, healthcare professionals and healthcare systems. LivaNova is headquartered in London, Greater London, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company LivaNova Plc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


LivaNova Plc Company Overview
LivaNova Plc Company Snapshot
LivaNova Plc Pipeline Products and Ongoing Clinical Trials Overview
LivaNova Plc – Pipeline Analysis Overview
Business Description
LivaNova Plc - Key Facts
LivaNova Plc - Major Products and Services
LivaNova Plc Pipeline Products by Development Stage
LivaNova Plc Ongoing Clinical Trials by Trial Status
LivaNova Plc Pipeline Products Overview
Aspire NP
Aspire NP Product Overview
aura6000
aura6000 Product Overview
aura6000 Clinical Trial
Bi-Flow
Bi-Flow Product Overview
Bi-Flow Clinical Trial
Caisson TMVR System
Caisson TMVR System Product Overview
Caisson TMVR System Clinical Trial
Centro Generator
Centro Generator Product Overview
CentroSR Generator
CentroSR Generator Product Overview
EpiTrace
EpiTrace Product Overview
Equilia
Equilia Product Overview
Griffin - Pulse Generator
Griffin - Pulse Generator Product Overview
Hattler Catheter
Hattler Catheter Product Overview
Intense Neuromodulation System - Heart Failure
Intense Neuromodulation System - Heart Failure Product Overview
LBATS
LBATS Product Overview
Microburst VNS Stimulator
Microburst VNS Stimulator Product Overview
Microburst VNS Stimulator Clinical Trial
Nerve Wrap
Nerve Wrap Product Overview
Next Generation Artificial Lung
Next Generation Artificial Lung Product Overview
Next Generation ECMO System
Next Generation ECMO System Product Overview
Next Generation Heart-Lung Machine
Next Generation Heart-Lung Machine Product Overview
Next Generation Wand - VNS Therapy
Next Generation Wand - VNS Therapy Product Overview
NINO
NINO Product Overview
Pediatric pVAD
Pediatric pVAD Product Overview
PhoenixRF SR
PhoenixRF SR Product Overview
Spiderflash AFIB
Spiderflash AFIB Product Overview
ULFED - <1L/min
ULFED - <1L/min Product Overview
ULFED - 250 mL/min
ULFED - 250 mL/min Product Overview
VITARIA System - Chronic Heart Failure
VITARIA System - Chronic Heart Failure Product Overview
VITARIA System - Chronic Heart Failure Clinical Trial
WaveLink
WaveLink Product Overview
LivaNova Plc - Key Competitors
LivaNova Plc - Key Employees
LivaNova Plc - Key Employee Biographies
LivaNova Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
LivaNova Plc, Recent Developments
Nov 12, 2021: LivaNova comments on decision by court of appeal of Milan
Nov 03, 2021: LivaNova Reports Third Quarter 2021 Results
Jul 28, 2021: LivaNova Reports Second Quarter 2021 Results and Appoints Alex Shvartsburg as Chief Financial Officer
Jul 16, 2021: CORCYM announces the first patient enrolled in MANTRA study
Jan 20, 2021: LivaNova to Host Conference Call for Fourth Quarter and Full-Year 2020 Results
Jan 05, 2021: Medistim partners with LivaNova as their new distributor for India
Dec 04, 2020: LivaNova to host satellite symposium on advances in Neuromodulation at American Epilepsy Society AES2020 virtual event
Jun 29, 2020: LivaNova to Host Conference Call for Second Quarter 2020 Results
Mar 09, 2020: LivaNova VNS Therapy System, Symmetry, granted CE Mark for difficult-to-treat depression
Feb 27, 2020: LivaNova partners with Verily for RECOVER clinical study
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: LivaNova Plc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: LivaNova Plc Pipeline Products by Equipment Type
Table 3: LivaNova Plc Pipeline Products by Indication
Table 4: LivaNova Plc, Key Facts
Table 5: LivaNova Plc, Major Products and Services
Table 6: LivaNova Plc Number of Pipeline Products by Development Stage
Table 7: LivaNova Plc Pipeline Products Summary by Development Stage
Table 8: LivaNova Plc Ongoing Clinical Trials by Trial Status
Table 9: LivaNova Plc Ongoing Clinical Trials Summary
Table 10: Aspire NP - Product Status
Table 11: Aspire NP - Product Description
Table 12: aura6000 - Product Status
Table 13: aura6000 - Product Description
Table 14: aura6000 - Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation
Table 15: Bi-Flow - Product Status
Table 16: Bi-Flow - Product Description
Table 17: Bi-Flow - Comparative Clinical Efficacy of Novel Bidirectional Peripheral Artery Cannula in Minimally Invasive Aortic Valve Surgery
Table 18: Caisson TMVR System - Product Status
Table 19: Caisson TMVR System - Product Description
Table 20: Caisson TMVR System - Clinical Investigation of the Caisson Transcatheter Mitral Valve Replacement (TMVR) System for Percutaneous Mitral Valve Replacement in Patients with Symptomatic Mitral Regurgitation
Table 21: Caisson TMVR System - Percutaneous Mitral Valve Replacement Evaluation Utilizing IDE Early Feasibility Study (PRELUDE)
Table 22: Centro Generator - Product Status
Table 23: Centro Generator - Product Description
Table 24: CentroSR Generator - Product Status
Table 25: CentroSR Generator - Product Description
Table 26: EpiTrace - Product Status
Table 27: EpiTrace - Product Description
Table 28: Equilia - Product Status
Table 29: Equilia - Product Description
Table 30: Griffin - Pulse Generator - Product Status
Table 31: Griffin - Pulse Generator - Product Description
Table 32: Hattler Catheter - Product Status
Table 33: Hattler Catheter - Product Description
Table 34: Intense Neuromodulation System - Heart Failure - Product Status
Table 35: Intense Neuromodulation System - Heart Failure - Product Description
Table 36: LBATS - Product Status
Table 37: LBATS - Product Description
Table 38: Microburst VNS Stimulator - Product Status
Table 39: Microburst VNS Stimulator - Product Description
Table 40: Microburst VNS Stimulator - Microburst VNS Therapy Feasibility Study in Subjects with Refractory Epilepsy
Table 41: Nerve Wrap - Product Status
Table 42: Nerve Wrap - Product Description
Table 43: Next Generation Artificial Lung - Product Status
Table 44: Next Generation Artificial Lung - Product Description
Table 45: Next Generation ECMO System - Product Status
Table 46: Next Generation ECMO System - Product Description
Table 47: Next Generation Heart-Lung Machine - Product Status
Table 48: Next Generation Heart-Lung Machine - Product Description
Table 49: Next Generation Wand - VNS Therapy - Product Status
Table 50: Next Generation Wand - VNS Therapy - Product Description
Table 51: NINO - Product Status
Table 52: NINO - Product Description
Table 53: Pediatric pVAD - Product Status
Table 54: Pediatric pVAD - Product Description
Table 55: PhoenixRF SR - Product Status
Table 56: PhoenixRF SR - Product Description
Table 57: Spiderflash AFIB - Product Status
Table 58: Spiderflash AFIB - Product Description
Table 59: ULFED - <1L/min - Product Status
Table 60: ULFED - <1L/min - Product Description
Table 61: ULFED - 250 mL/min - Product Status
Table 62: ULFED - 250 mL/min - Product Description
Table 63: VITARIA System - Chronic Heart Failure - Product Status
Table 64: VITARIA System - Chronic Heart Failure - Product Description
Table 65: VITARIA System - Chronic Heart Failure - Autonomic Regulation Therapy to Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction
Table 66: WaveLink - Product Status
Table 67: WaveLink - Product Description
Table 68: LivaNova Plc, Key Employees
Table 69: LivaNova Plc, Key Employee Biographies
Table 70: LivaNova Plc, Subsidiaries
Table 71: Glossary
List of Figures
Figure 1: LivaNova Plc Pipeline Products by Equipment Type
Figure 2: LivaNova Plc Pipeline Products by Development Stage
Figure 3: LivaNova Plc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings